Pieris Pharmaceuticals Inc.
13F holders, Q1 2024 (March 31)41holders
3famous investors
$0.19avg. 13F price*
At the end of Q1 2024, 41 institutions reported holding Pieris Pharmaceuticals Inc. in their 13F filings. The largest holders were BVF Inc. ($3.8M), Lynx1 Capital Management LP ($1.6M) and Goldman Sachs Group Inc. ($332K). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Pieris Pharmaceuticals Inc.
- CUSIP
- 720795103
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $57K |
| Exits | 8 | $377K |
Ownership 41 holders
| BVF Inc. | 0.10% | No change | 20,609,863 | $3.8M |
| Lynx1 Capital Management LP | 0.41% | Reduce -10.2% | 8,779,162 | $1.6M |
| Goldman Sachs Group Inc. | 0.00% | Add +0.0% | 22,638 | $332K |
| Renaissance Technologies | 0.00% | Add +34.2% | 1,429,588 | $262K |
| BlackRock Inc. | 0.00% | Reduce -0.0% | 1,037,639 | $190K |
| Citadel Advisors | 0.00% | Reduce -18.7% | 967,235 | $177K |
| Acadian Asset Management LLC | 0.00% | No change | 962,358 | $175K |
| Vanguard Group Inc. | 0.00% | No change | 907,390 | $166K |
| Geode Capital Management, LLC | 0.00% | Add +1.5% | 772,784 | $142K |
| CM Management, LLC | 0.09% | Reduce -23.3% | 575,000 | $105K |
| Northern Trust Corp. | 0.00% | No change | 243,592 | $45K |
| State Street Corp. | 0.00% | No change | 222,819 | $41K |
| Prudential Financial Inc. | 0.00% | Add +100.4% | 220,800 | $40K |
| Millennium Management | 0.00% | Add +27.0% | 211,745 | $39K |
| Squarepoint Ops LLC | 0.00% | New | 145,833 | $27K |
| Summit Trail Advisors, LLC | 0.00% | New | 140,000 | $26K |
| Citigroup Inc. | 0.00% | No change | 88,585 | $16K |
| Two Sigma Securities, LLC | 0.00% | Add +278.0% | 58,265 | $11K |
| UBS Group AG | 0.00% | Add +727.9% | 51,994 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +426.6% | 42,742 | $8K |
| Two Sigma Advisers, LP | 0.00% | Reduce -2.0% | 33,900 | $6K |
| NJ State Employees Deferred Compensation Plan | 0.00% | No change | 30,000 | $5K |
| Raymond James & Associates | 0.00% | No change | 30,000 | $5K |
| B. Riley Wealth Advisors, Inc. | 0.00% | New | 17,000 | $5K |
| Group One Trading LLC | 0.00% | Add +281.9% | 25,700 | $5K |
| XTX Topco Ltd | 0.00% | Reduce -47.7% | 20,756 | $4K |
| Commerce Bank | 0.00% | No change | 20,000 | $4K |
| Kestra Advisory Services, LLC | 0.00% | No change | 17,500 | $3K |
| Orange Investment Advisors, Inc. | 0.00% | No change | 14,000 | $3K |
| Cerity Partners LLC | 0.00% | No change | 10,300 | $2K |
| US Bancorp \de | 0.00% | No change | 10,280 | $2K |
| Morgan Stanley | 0.00% | No change | 6,856 | $1K |
| Bank of America Corp. | 0.00% | Add +4137.9% | 6,145 | $1K |
| Wells Fargo & Company | 0.00% | Add +17.1% | 5,573 | $1K |
| Barclays PLC | 0.00% | No change | 5,006 | $917 |
| JPMorgan Chase & Co. | 0.00% | Add +0.9% | 1,989 | $365 |
| Truvestments Capital LLC | 0.00% | No change | 1,120 | $205 |
| Osaic Holdings, Inc. | 0.00% | No change | 516 | $95 |
| Allworth Financial LP | 0.00% | No change | 350 | $65 |
| Royal Bank of Canada | 0.00% | Reduce -52.5% | 272 | $0 |
| Cutler Group LLC / CA | 0.00% | No change | 4,500 | $0 |
"% of holder's portfolio" is PIERIS PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Pieris Pharmaceuticals Inc. the manager owns.